Orios XT Viable Cellular Allograft with Fibers

Brand Origin and Manufacturing

Orios XT is a viable cellular allograft with fibers, developed and manufactured by Spinal Elements, Inc., a privately held medical device company based in the United States. The product is designed to enhance bone fusion in spinal surgeries by providing a moldable, cohesive material that combines viable spine-derived cells with demineralized bone matrix and cortical fibers. This composition aims to improve the healing process and patient outcomes in spinal procedures.

Ownership and Company Details

Spinal Elements, Inc. is the original creator and current owner of the Orios XT brand. As a privately held company headquartered in the United States, Spinal Elements focuses on developing innovative spinal surgery solutions. The company is not a subsidiary of any other organization, maintaining independent operations and ownership.

Product Details

Orios XT is preserved using a non-DMSO cryoprotectant, eliminating the need for rinsing or decanting steps after thawing. It offers a four-hour working window for implantation, facilitating ease of use in surgical settings. The product has demonstrated high fusion rates in clinical studies, with a 96% fusion rate at 12 months in a minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) study and a 94% fusion rate at 12 months in a minimally invasive lateral lumbar interbody fusion (MIS-LLIF) study. These outcomes underscore the product's efficacy in promoting bone fusion in spinal surgeries.